#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Athero Review - Issue 2/2025

Editorial

79

Reviews

83

Bempedoic acid – an efficient and safe lipid-lowering treatment in the light of the latest findings

Šárka Tesařová, Michal Vrablík

89

Factors influencing hypolipidemic treatment of patients after acute coronary syndrome, ischemic stroke, and transient ischemic attack in cardiological and neurological outpatient care in Slovakia

Štefan Tóth, Lenka Kováčová, Martin Selvek, Beata Saal, Roman Mužik, Ivan Tkáč

105

Fats and oils from the perspective of scientific studies, the media and the internet

Jiří Brát

111

Evinacumab in the treatment of homozygous familial hypercholesterolemia: data from real-world clinical practice and case report

Vladimír Bláha

116

Effect of once-weekly semaglutide on functional capacity in patients with peripheral arterial disease and type 2 diabetes: results from the STRIDE study

Michal Vrablík

121

Coronary events are preventable – so don't miss this opportunity: case report

Martin Šatný

127

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – the current challenges for its management

Zuzana Zafarová

135

Where does the Czech Republic have a head start, and where does it need to catch up? International Summit on Lipoprotein(a) – Brussels, March 2025

Kristýna Čillíková

From International Literature

137

Research on remarkable articles from international literature

Eva Tůmová

Annoucements

139

XXXIXth conference on hyperlipoproteinemias – Šobraʼs Day 2025

Kristýna Čillíková, Karolína Vašků

Athero Review

Issue 2

2025 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#